RE/MAX (RMAX) Reports Q2: Everything You Need To Know Ahead Of Earnings

RE/MAX (NYSE: RMAX) is set to report Q2 earnings Thursday. The company previously missed revenue and profit expectations, with Q1 revenue of $70.23 million, down 5.7% year on year, and it reported 149,192 agents, up 2.1%. Analysts expect Q2 revenue to be flat. RMAX shares are down 14.2% over the past month; average price target is $11.40 vs $9.73.

Original reporting
Published Aug 5, 2026, 3:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 4:45 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RE/MAX (RMAX) Reports Q2: Everything You Need To Know Ahead Of Earnings — source image
Decision brief

The 30-second read

$RMAXNeutralMed
01

Why it matters

Traders can use the stated consensus setup (flat YoY revenue expectation, reconfirmed estimates) and the prior-quarter miss pattern to frame scenarios for EPS and EBITDA versus expectations.

02

Market read

This is a pre-earnings expectations and peer read-across setup for RE/MAX, with the main actionable element being the upcoming earnings timing and the stated consensus trajectory.

03

What to watch

The article does not provide segment-level drivers, guidance changes, or agent productivity metrics that often explain franchise earnings surprises.

Relevance 5/10Novelty 4/10Timing: ahead of Thursday afternoon earnings

Background

RE/MAX missed revenue and profitability-related analyst estimates last quarter and is now heading into its next earnings release.

Company-level read

Ticker impact

$RMAXNeutralMedium confidence
Context

RE/MAX is set to report earnings Thursday, with the article citing recent revenue/EPS/EBITDA misses and current consensus expectations.

Expected impact

Likely elevated volatility around the report, with direction dependent on whether revenue stabilizes and whether EPS/EBITDA misses narrow.

Evidence & confidence

The article provides pre-earnings positioning details (consensus reconfirmation, prior misses, current price vs average analyst target) but does not disclose any new guidance or fresh company-specific datapoint beyond what is already framed for the upcoming release.

Market effects

Real estate services peers are referenced as having reported results, which can influence read-across expectations for franchise operators.

No specific regional impact described.

No global macro or cross-border catalyst described.

Counterpoint

Even with prior revenue misses, the stock’s underperformance versus the analyst target could mean expectations are already low, increasing the odds of a less-bad outcome.

Key entities

  • RE/MAX

    NYSE-listed real estate franchise company reporting Q2 earnings Thursday afternoon.

  • Compass

    Peer referenced as having delivered strong YoY revenue growth and an earnings beat.

  • JLL

    Peer referenced as having reported revenue growth and a modest beat with a positive stock reaction.

Related articles

$RMAXMed

RE/MAX (NYSE:RMAX) Misses Q2 CY2026 Sales Expectations

RE/MAX (NYSE:RMAX) reported Q2 CY2026 results that missed Wall Street expectations. Revenue fell 5.8% year on year to $68.51 million, and non-GAAP adjusted EPS was $0.32, down from $0.39 and 18.6% below consensus. Analysts expect revenue to rise 3.3% and full-year EPS to increase from $1.15 to $1.33.

$RMAXMedAI 8/10

RE/MAX HOLDINGS, INC. REPORTS SECOND QUARTER 2026 RESULTS

RE/MAX Holdings (NYSE: RMAX) reported Q2 2026 revenue of $68.5M, down 5.8% year over year, and adjusted EBITDA of $22.9M, down 12.6%. GAAP net loss was $4.3M, or -$0.20 per diluted share. The company also disclosed a planned merger with The Real Brokerage, offering Real REMAX Group shares or $13.80 cash per RMAX share, expected to close in H2 2026.

$RMAXMed

RE/MAX Holdings, Inc. (RMAX): Results of Operations and Financial Condition

RE/MAX Holdings, Inc. (RMAX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622438d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 RE/MAX HOLDINGS, INC. REPORTS SECOND QUARTER 2026 RESULTS Total Second Quarter Revenue of $68.5 Million, Adjusted EBITDA of $22.9 Million DENVER, August 6, 2026 Second Quarter 2026 Highlights (Compared to second quarter 2

$RMAXMedAI 8/10

Why RE/MAX (RMAX) Stock Is Up Today

RE/MAX (RMAX) shares rose after the DOJ granted early termination of the HSR waiting period for its proposed merger with The Real Brokerage, removing a key antitrust review hurdle. The deal still requires shareholder approvals. RMAX closed at $10.71, up 0.9% on the day.

$RMAXMedAI 8/10

Real-REMAX Deal Clears DOJ and FTC Scrutiny

Real’s SEC filing says the DOJ granted early termination of the antitrust waiting period for Real’s $880 million bid to buy RE/MAX. The FTC says early termination occurs only after both agencies complete review and plan no enforcement during the period. Shareholder approval is set for Aug. 14. Real shares rose about 4% after the filing.

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.